title: Impacts of long-term treatments with testosterone replacement and pioglitazone on glucose and lipid metabolism in male patients with Werner's syndrome.
authors.forename: Hiroyasu
authors.initials: H
authors.lastname: Yamamoto
authors.forename: Shogo
authors.initials: S
authors.lastname: Kurebayashi
authors.forename: Haruhiko
authors.initials: H
authors.lastname: Kouhara
authors.forename: Kazutomi
authors.initials: K
authors.lastname: Yoshiuchi
authors.forename: Munehide
authors.initials: M
authors.lastname: Matsuhisa
authors.forename: Yoshimitsu
authors.initials: Y
authors.lastname: Yamasaki
authors.forename: Soji
authors.initials: S
authors.lastname: Kasayama
mesh_terms: D000328:Adult; D001786:Blood Glucose / Q000378:metabolism*; D004359:Drug Therapy, Combination; D005947:Glucose / Q000378:metabolism*; D020249:Hormone Replacement Therapy; D006801:Humans; D007333:Insulin Resistance; D050356:Lipid Metabolism / Q000187:drug effects*; D008297:Male; D000077205:Pioglitazone; D013739:Testosterone / Q000008:administration & dosage* / Q000627:therapeutic use; D045162:Thiazolidinediones / Q000008:administration & dosage* / Q000627:therapeutic use; D016896:Treatment Outcome; D014898:Werner Syndrome / Q000188:drug therapy* / Q000378:metabolism
chemical_list: D001786:Blood Glucose; D045162:Thiazolidinediones; D013739:Testosterone; D005947:Glucose; D000077205:Pioglitazone